Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial

Single-session cardiac stereotactic radiation therapy (SBRT) has demonstrated promising results for patients with refractory ventricular tachycardia (VT). However, the full safety profile of this novel treatment remains unknown and very limited data from prospective clinical multicenter trials are a...

Full description

Saved in:
Bibliographic Details
Main Authors: Krug, David (Author) , Zaman, Adrian (Author) , Eidinger, Lina (Author) , Grehn, Melanie (Author) , Boda-Heggemann, Judit (Author) , Rudic, Boris (Author) , Mehrhof, Felix (Author) , Boldt, Leif-Hendrik (Author) , Hohmann, Stephan (Author) , Merten, Roland (Author) , Bürgy, Daniel (Author) , Fleckenstein, Jens (Author) , Kluge, Anne (Author) , Rogge, Annette (Author) , Both, Marcus (Author) , Rades, Dirk (Author) , Tilz, Roland Richard (Author) , Olbrich, Denise (Author) , König, Inke R. (Author) , Siebert, Frank-Andre (Author) , Schweikard, Achim (Author) , Vonthein, Reinhard (Author) , Bonnemeier, Hendrik (Author) , Dunst, Jürgen (Author) , Blanck, Oliver (Author)
Format: Article (Journal)
Language:English
Published: July 2023
In: Strahlentherapie und Onkologie
Year: 2023, Volume: 199, Issue: 7, Pages: 621-630
ISSN:1439-099X
DOI:10.1007/s00066-023-02091-9
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-023-02091-9
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00066-023-02091-9
Get full text
Author Notes:David Krug, Adrian Zaman, Lina Eidinger, Melanie Grehn, Judit Boda-Heggemann, Boris Rudic, Felix Mehrhof, Leif-Hendrik Boldt, Stephan Hohmann, Roland Merten, Daniel Buergy, Jens Fleckenstein, Anne Kluge, Annette Rogge, Marcus Both, Dirk Rades, Roland Richard Tilz, Denise Olbrich, Inke R. König, Frank-Andre Siebert, Achim Schweikard, Reinhard Vonthein, Hendrik Bonnemeier, Jürgen Dunst, Oliver Blanck
Description
Summary:Single-session cardiac stereotactic radiation therapy (SBRT) has demonstrated promising results for patients with refractory ventricular tachycardia (VT). However, the full safety profile of this novel treatment remains unknown and very limited data from prospective clinical multicenter trials are available.
Item Description:Online veröffentlicht: 7. June 2023
Gesehen am 19.09.2024
Physical Description:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-023-02091-9